mesowatch
HomeCT Scanning Not Reliable for Correct Diagnosis of Pleural Mesothelioma, says new study
divider

CT Scanning Not Reliable for Correct Diagnosis of Pleural Mesothelioma, says new study

CT scan of lungs for pleural mesothelioma

Researchers from the Queen Elizabeth University Hospital, Glasgow have reported that Computed Tomography (CT) Imaging is not accurate enough to diagnose pleural mesothelioma or other pleural malignancies.

Their tests on 315 patients have revealed that CT scans showed varying results in either ruling out or confirming the mesothelioma in more than half of the cases.

In their research report, “The diagnostic performance of routinely acquired and reported computed tomography imaging in patients presenting with suspected pleural malignancy”, published in the journal “Lung Cancer” on 13th November, 2016, the Scottish researchers have highlighted the fact that accuracy rate of CT scan, performed for diagnosis of pleural malignancies, was only 58%.

CT Scan Imaging and the Diagnosis of Mesothelioma

When a person with an occupational history of high asbestos exposure and symptoms like relentless coughing, wheezing, chest pain, and sudden weight loss, comes to see a physician; while including malignant mesothelioma in his differential diagnosis, the physician goes through various tests like CT scans and X- Rays to accurately diagnose the problem.

CT scan is the radiological method used for the diagnosis of mesothelioma or other pleural malignancies, in which cross-sectional images are created with special X-rays, which are compiled to form a three-dimensional model.

CT scanning is thought to be one of the most advanced and highly accurate diagnostic tools, but according to this recent research, approximately half of the benign CT scan results (showing the absence of any malignancy of -54% of total patients) were later diagnosed with a pleural malignancy. Indicating that this method is not as specific and sensitive as it was originally accepted.

To assess the reliability of CT scanning, this study was performed on 315 patients, which were diagnosed with mesothelioma or other pleural malignancies between January 2014 and April 2016.

CT Scan Results

“Probable Malignant effusion”, “suspicion of malignancy”, and “disseminated malignancy” are considered to be the malignant reports from CT scan imaging. While reports like “No cause identified”, “intermediate”, or “no evident malignancy” are considered to be benign results.

CT scan correctly diagnosed pleural mesothelioma in 58% of the patients, and negatively predicted 54% of the cases. While the scans interoperated by thoracic radiologists resulted in the correct diagnosis of mesothelioma.

The study has emphasized the presence of specialized thoracic radiologists because the accuracy of results in specialized radiology reporting was 68%, while in no specialized thoracic reporting the accuracy was 53%.

Combination of Diagnostic Methods

According to the report, other diagnostic procedures including pleural biopsy must also be incorporated with CT, thus to get a more accurate and quick diagnosis. Because delayed diagnosis significantly poses a bad impact on the survival rate of mesothelioma patients.

In other studies, positron emission tomography (PET) combined with CT scans has also been described as an improved diagnostic method for accurate diagnosis of mesothelioma. In PET, radioactive tracers marked with special dye, are used to highlight the area with the higher metabolic rate. This can also indicate cancer.

Conclusion

The researchers concluded that relying solely on the CT scan results is not sufficient enough to confirm or negate the presence of pleural malignancy or mesothelioma. For the accurate diagnosis of pleural mesothelioma and other pleural malignancies, a combination of CT scan with Positron Emission Tomography (PET) is very important.

Amna Anees

Reading Time: 1 mins

Published On: February 14, 2017

Amna Anees - author

Amna is a molecular biologist and has a deep interest in the field of health and medicine. She has worked in the field of proteomics and plants molecular biology. Being a biologist herself, she has developed an interest in the field of therapeutic studies of mesothelioma and related researches.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer